Design and Synthesis of Potent, Selective Inhibitors of Matriptase

被引:58
作者
Colombo, Eloic [1 ]
Desilets, Antoine [1 ]
Duchene, Dominic [2 ]
Chagnon, Felix [1 ]
Najmanovich, Rafael [2 ]
Leduc, Richard [1 ]
Marsault, Eric [1 ]
机构
[1] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Biochem, Sherbrooke, PQ J1H 5N4, Canada
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2012年 / 3卷 / 07期
基金
加拿大健康研究院;
关键词
matriptase; type II transmembrane serine protease; slow tight-binding inhibitor; TRANSMEMBRANE SERINE-PROTEASE; AUTOSOMAL RECESSIVE ICHTHYOSIS; IDENTIFICATION; ACTIVATOR; MUTATION;
D O I
10.1021/ml3000534
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Matriptase is a member of the type II transmembrane serine protease family. Several studies have reported deregulated matriptase expression in several types of epithelial cancers, suggesting that matriptase constitutes a potential target for cancer therapy. We report herein a new series of slow, tight binding inhibitors of matriptase, which mimic the P1-P4 substrate recognition sequence of the enzyme. Preliminary structure-activity relationships indicate that this benzothiazole-containing RQAR-peptidomimetic is a very potent inhibitor and possesses a good selectivity for matriptase versus other serine. proteases. A molecular model was generated to elucidate the key contacts between inhibitor 1 and matriptase.
引用
收藏
页码:530 / 534
页数:5
相关论文
共 33 条
[1]   Membrane-Anchored Serine Proteases in Health and Disease [J].
Antalis, Toni M. ;
Bugge, Thomas H. ;
Wu, Qingyu .
PROTEASES IN HEALTH AND DISEASE, 2011, 99 :1-50
[2]   Autosomal recessive ichthyosis with hypotrichosis caused by a mutation in ST14, encoding type II transmembrane serine protease matriptase [J].
Basel-Vanagaite, Lina ;
Attia, Revital ;
Ishida-Yamamoto, Akemi ;
Rainshtein, Limor ;
Ben Amitai, Dan ;
Lurie, Raziel ;
Pasmanik-Chor, Metsada ;
Indelman, Margarita ;
Zvulunov, Alex ;
Saban, Shirley ;
Magal, Nurit ;
Sprecher, Eli ;
Shohat, Mordechai .
AMERICAN JOURNAL OF HUMAN GENETICS, 2007, 80 (03) :467-477
[3]   Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides [J].
Beliveau, Francois ;
Desilets, Antoine ;
Leduc, Richard .
FEBS JOURNAL, 2009, 276 (08) :2213-2226
[4]   The Protein Data Bank [J].
Berman, HM ;
Westbrook, J ;
Feng, Z ;
Gilliland, G ;
Bhat, TN ;
Weissig, H ;
Shindyalov, IN ;
Bourne, PE .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :235-242
[5]  
BIETH JG, 1995, METHOD ENZYMOL, V248, P59
[6]  
Copeland R., 2000, PRACTICAL INTRO STRU, P1
[7]   In-depth study of tripeptide-based α-ketoheterocycles as inhibitors of thrombin.: Effective utilization of the S1′ subsite and its implications to structure-based drug design [J].
Costanzo, MJ ;
Almond, HR ;
Hecker, LR ;
Schott, MR ;
Yabut, SC ;
Zhang, HC ;
Andrade-Gordon, P ;
Corcoran, TW ;
Giardino, EC ;
Kauffman, JA ;
Lewis, JM ;
de Garavilla, L ;
Haertlein, BJ ;
Maryanoff, BE .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :1984-2008
[8]   Inhibition of human matriptase by eglin c variants [J].
Désilets, A ;
Longpré, JM ;
Beaulieu, ME ;
Leduc, R .
FEBS LETTERS, 2006, 580 (09) :2227-2232
[9]   Mutation G827R in matriptase causing autosomal recessive ichthyosis with hypotrichosis yields an inactive protease [J].
Desilets, Antoine ;
Beliveau, Francois ;
Vandal, Guillaume ;
McDuff, Francois-Olivier ;
Lavigne, Pierre ;
Leduc, Richard .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (16) :10535-10542
[10]   Structure-based approach for the discovery of bis-benzamidines as novel inhibitors of matriptase [J].
Enyedy, IJ ;
Lee, SL ;
Kuo, AH ;
Dickson, RB ;
Lin, CY ;
Wang, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (09) :1349-1355